CC214-2 is an oral active and selective mTOR kinase inhibitor. CC214-2 targets to both of mTORC1 (pS6) and mTORC2 (pAktS473). CC214-2 induces autophagy, which is a potential target for host-directed therapy (HDT) in tuberculosis. CC214-2 exhibits synergi
Molecular Weight:
383.44
Purity:
98.41
CAS Number:
[1228012-18-7]
Formula:
C20H25N5O3
Target:
Autophagy,mTOR
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted